| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| Other Sizes |
| Targets |
|
|
|---|---|---|
| ln Vitro |
|
|
| ln Vivo |
|
|
| References | ||
| Additional Infomation |
Cg200745 has been used in clinical trials for the treatment of solid tumors. Ivatinositol is a histone deacetylase (HDAC) inhibitor with potential antitumor activity. Ivatinositol inhibits the catalytic activity of HDAC, leading to the accumulation of highly acetylated chromatin histones, which in turn induces chromatin remodeling and altered gene expression patterns. In particular, this drug enhances histone acetylation of the tumor suppressor gene p53. This leads to p53 accumulation, which in turn activates p53-dependent transcription, ultimately inducing tumor cell apoptosis. HDAC is an enzyme upregulated in various tumor types that enables the deacetylation of chromatin histones.
|
| Molecular Formula |
C24H33N3O4
|
|---|---|
| Molecular Weight |
427.54
|
| Exact Mass |
427.247
|
| CAS # |
936221-33-9
|
| Related CAS # |
Ivaltinostat formic
|
| PubChem CID |
16117309
|
| Appearance |
White to off-white solid
|
| Density |
1.148±0.06 g/cm3 (20 °C, 760 mmHg)
|
| LogP |
4.06
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
13
|
| Heavy Atom Count |
31
|
| Complexity |
579
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
O(C1C=CC=C2C=CC=CC=12)C/C(/C(NCCCN(C)C)=O)=C\CCCCC(NO)=O
|
| InChi Key |
AUGCSOFQTDKPSO-RGVLZGJSSA-N
|
| InChi Code |
InChI=1S/C24H33N3O4/c1-27(2)17-9-16-25-24(29)20(11-4-3-5-15-23(28)26-30)18-31-22-14-8-12-19-10-6-7-13-21(19)22/h6-8,10-14,30H,3-5,9,15-18H2,1-2H3,(H,25,29)(H,26,28)/b20-11+
|
| Chemical Name |
(E)-N-[3-(dimethylamino)propyl]-N'-hydroxy-2-(naphthalen-1-yloxymethyl)oct-2-enediamide
|
| Synonyms |
CG 200745 CG-200745 CG200745
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~100 mg/mL (~233.9 mM; with ultrasonication)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (5.85 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), Clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of 20% SBE-β-CD saline and mix well. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (5.85 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), Clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of DMSO stock solution (25.0 mg/mL) to 900 μL of corn oil and mix well. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3390 mL | 11.6948 mL | 23.3896 mL | |
| 5 mM | 0.4678 mL | 2.3390 mL | 4.6779 mL | |
| 10 mM | 0.2339 mL | 1.1695 mL | 2.3390 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
